| Description | Voxilaprevir is an inhibitor of hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease. |
| Synonyms | 维昔普维, 伏西瑞韦 |
| molecular weight | 868.93 |
| Molecular formula | C40H52F4N6O9S |
| CAS | 1535212-07-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 22.5 mg/mL (25.89 mM) |
| References | 1. Bourlière, Marc, Gordon S C , Flamm S L , et al. Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.[J]. N Engl J Med, 2017, 376(22):2134-2146. |